Johns Hopkins University is launching a new center for psychedelic research that will use psychedelic drugs to study the mind…
Super UserSeptember 9, 2019
Vensana Capital—an independent, medtech-focused venture capital investment firm supported by Versant Ventures—has launched with a $225 million fund and ambitions…
Super UserSeptember 9, 2019
Organizers of the $150K "Make Your Medical Device Pitch for Kids!" competition today announced the 12 finalists who are advancing…
Super UserSeptember 9, 2019
Making a therapeutic that contains biological components is just the start of creating a medicine. Then, biopharmaceutical companies must capture…
Super UserSeptember 9, 2019
Bristol-Myers Squibb has allied with biotech accelerator BioMotiv. The deal sets Bristol-Myers up to found and fund biotechs with BioMotiv…
Super UserSeptember 9, 2019
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy…
Super UserSeptember 9, 2019
Low interest rates and high stock valuations are fueling U.S. life sciences CEOs’ growing appetite for mergers and acquisitions, KPMG’s…
Super UserSeptember 9, 2019
It’s a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators'…
Super UserSeptember 9, 2019
Biotech is booming across the country, especially in the top biotech clusters like Boston, San Francisco, New York and in…
Super UserSeptember 9, 2019